世界の移植片対宿主病治療薬市場...市場調査レポートについてご紹介

【英文タイトル】OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 12
1.1 List of Tables 18
1.2 List of Figures 22
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 27
3.1.3 Classification and Prognosis 28
3.2 Symptoms 30
4 Epidemiology 32
4.1 Disease Background 32
4.2 Risk Factors and Comorbidities 33
4.3 Global Trends 35
4.4 Forecast Methodology 36
4.4.1 Sources Used 38
4.4.2 Sources Not Used 44
4.4.3 Diagnosed Incident Cases of HSCTs 45
4.4.4 Diagnosed Incident Cases of Autologous HSCTs 47
4.4.5 Diagnosed Incident Cases of Allogeneic HSCTs 48
4.4.6 Diagnosed Incident Cases of aGVHD 49
4.4.7 Four-Year Diagnosed Prevalent Cases of aGVHD 49
4.4.8 Diagnosed Incident Cases of cGVHD 50
4.4.9 Five-Year Diagnosed Prevalent Cases of cGVHD 50
4.5 Epidemiological Forecast for GVHD (2013-2023) 51
4.5.1 Diagnosed Incident Cases of HSCTs 51
4.5.2 Diagnosed Incident Cases of Autologous HSCTs 53
4.5.3 Diagnosed Incident Cases of Allogeneic HSCTs 54
4.5.4 Diagnosed Incident Cases of aGVHD 56
4.5.5 Four-Year Diagnosed Prevalent Cases of aGVHD 58
4.5.6 Diagnosed Incident Cases of cGVHD 60
4.5.7 Five-Year Diagnosed Prevalent Cases of cGVHD 61
4.6 Discussion 63
4.6.1 Epidemiological Forecast Insight 63
4.6.2 Limitations of the Analysis 64
4.6.3 Strengths of the Analysis 65
5 Current Treatment Options 66
5.1 Overview 66
5.2 Product Profiles – Major Therapies 68
5.2.1 Methylprednisolone (numerous brand and generic names) 68
5.2.2 Cyclosporine (numerous brands and generic names) 72
5.2.3 Anti-Thymocyte Globulin (ATG) Therapies 77
5.3 Product Profiles – Off-Label Therapies 82
5.3.1 Biologics (Tumor Necrosis Factor (TNF)α Inhibitors, Interleukin-2 Receptor α (CD25) Inhibitors, Co-Stimulatory Blockers and Other Biologics) 82
5.3.2 Small Immunosuppressive Molecules (mTOR Inhibitors, Solid Organ Transplant Therapies, and Anti-Neoplastic Therapies) 101
6 Unmet Need and Opportunity 116
6.1 Overview 116
6.2 Lack of Randomized Clinical Trials 119
6.2.1 Unmet Need 119
6.2.2 Gap Analysis 119
6.2.3 Opportunity 120
6.3 No Consensus Regarding Clinical Trial Endpoints 120
6.3.1 Unmet Need 120
6.3.2 Gap Analysis 120
6.3.3 Opportunity 121
6.4 Optimization of Prophylactic Measures 121
6.4.1 Unmet Need 121
6.4.2 Gap Analysis 122
6.4.3 Opportunity 122
6.5 Lack of Standardized Protocols for Established and Off-Label Therapies 123
6.5.1 Unmet Need 123
6.5.2 Gap Analysis 123
6.5.3 Opportunity 124
6.6 Improved Treatment Outcomes for Patients Who Develop Toxicities 124
6.6.1 Unmet Need 124
6.6.2 Gap Analysis 125
6.6.3 Opportunity 125
6.7 Desire for Treatments that Exhibit Longer-Lasting Efficacy Profiles 125
6.7.1 Unmet Need 125
6.7.2 Gap Analysis 126
6.7.3 Opportunity 127
6.8 Management of SR-aGVHD Patients 127
6.8.1 Unmet Need 127
6.8.2 Gap Analysis 128
6.8.3 Opportunity 128
6.9 Management of Sclerotic cGVHD Patients 128
6.9.1 Unmet Need 128
6.9.2 Gap Analysis 129
6.9.3 Opportunity 129
6.10 Improved Prognosis for Patients with Lung Involvement 130
6.10.1 Unmet Need 130
6.10.2 Gap Analysis 130
6.10.3 Opportunity 131
7 Research and Development Strategies 132
7.1 Overview 132
7.1.1 Improvement of Prophylactic Regimens 132
7.1.2 Inhibition of T-Cell Proliferation and Activation 133
7.1.3 Adopting Treatments from Hematologic Indications 134
7.1.4 Targeting Niche Subgroups Within GVHD 135
7.2 Current Clinical Trial Design 136
7.2.1 Current Trial Designs are Dependent on the Stage Within the Treatment Algorithm That a Product is Targeting 136
7.2.2 Lack of Consensus on Clinical Endpoints in Current Trial Designs 137
7.2.3 Patient Exclusion Issues in Current Trial Designs 137
7.2.4 Current Trial Design of Key Pipeline Products 137
7.3 Future Clinical Trial Design 139
7.3.1 Future Trial Designs Need to Incorporate Randomization 139
7.3.2 Future Trial Designs Need to Incorporate Conditioning Regimens and Hematological Patients 140
7.3.3 Companies Behind Off-Label Therapies Should Strategize to Conduct Randomized Studies 140
7.3.4 Design of Early-Phase Clinical Trials for Cellular and Gene Therapy Products Accommodates 2014 Guidance from the FDA 140
8 Pipeline Assessment 141
8.1 Overview 141
8.2 Promising Drugs in Clinical Development 142
8.2.1 Leukotac (inolimomab) 142
8.2.2 Begedina (BT 5/9) 147
8.2.3 Budenofalk (budesonide) 150
8.2.4 ATG-Fresenius (EZ-2053) 153
8.2.5 Prochymal (remestemcel-L) 156
8.2.6 MultiStem (modified mesenchymal stem cells) 161
8.2.7 Uvadex (Extracorporeal Photophoresis) 164
8.2.8 orBec (beclomethasone dipropionate) 168
8.3 Innovative Early-Stage Approaches 171
8.3.1 Targeting Regulatory T Cells 174
8.3.2 Mesenchymal Stem Cell Therapies 175
8.3.3 Immunomodulatory Cell Surface Receptor Inhibitors 176
8.3.4 IL-6 Inhibitors 177
9 Pipeline and Off-Label Valuation Analysis 178
9.1 Clinical Benchmarking of Key Pipeline and Off-Label Drugs 178
9.1.1 GVHD Prophylaxis 178
9.1.2 Acute GVHD 181
9.1.3 Chronic GVHD 185
9.2 Commercial Benchmarking of Key Pipeline and Off-Label Drugs 186
9.2.1 GVHD Prophylaxis 187
9.2.2 Acute GVHD 189
9.2.3 Chronic GVHD 191
9.3 Competitive Assessment 193
9.3.1 GVHD Prophylaxis 193
9.3.2 Acute GVHD 194
9.3.3 Chronic GVHD 196
9.4 Top-Line Five-Year Forecast 198
9.4.1 US 203
9.4.2 5EU 207
10 Appendix 211
10.1 Bibliography 211
10.2 Abbreviations 230
10.3 Methodology 236
10.4 Forecasting Methodology 236
10.4.1 Diagnosed GVHD Patients 236
10.4.2 Percent Drug-Treated Patients 237
10.4.3 Drugs Included in Each Therapeutic Class 237
10.4.4 Launch and Patent Expiry Dates 238
10.4.5 General Pricing Assumptions 238
10.4.6 Individual Drug Assumptions 239
10.4.7 Generic Erosion 246
10.4.8 Pricing of Pipeline Agents 246
10.5 Physicians and Specialists Included in This Study 247
10.6 About the Authors 249
10.6.1 Author 249
10.6.2 Reviewer 249
10.6.3 Epidemiologist 250
10.6.4 Global Head of Healthcare 250
10.7 About GlobalData 251
10.8 Disclaimer 251


【レポート販売概要】

■ タイトル:世界の移植片対宿主病治療薬市場
■ 英文:OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018
■ 発行日:2014年8月20日
■ 調査会社:GlobalData
■ 商品コード:GDHC021POA
■ 調査対象地域:グローバル
  • ブラジルの風力発電市場2016:発電能力、生産、投資動向、制度、企業
    Wind Power in Brazil, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Wind Power in Brazil, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry analy …
  • コートジボワールの損害保険市場
    "Trends and Opportunities in Cote d’Ivoire Non-Life Insurance Industry to 2018: Market Profile" is the result of extensive research into the non life insurance segment in Cote d’Ivoire. It provides insights into the market trends, market size, growth prospects and market efficiency in the Ivoirian non life insurance market.
  • 世界の冷凍ベーカリー市場動向及び予測
    Frozen bakery makes up a significant portion of the food processing market, globally. Bakery trade is one of the most profitable fields and most bakeries have good return on capital. This industry maintains the characteristics of a stable and robust sector throughout the world. This category also includes those frozen baked products which are used in the manufacturing of other items or used in ins …
  • 紫外線(日光)角化症(Actinic (Solar) Keratosis):治療薬開発パイプライン動向(2015年上半期版)
    Actinic (Solar) Keratosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Actinic (Solar) Keratosis - Pipeline Review, H1 2015’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Actinic (Solar) Keratosis, complete with comparative analysis at various stages, therapeutics asse …
  • ディジタルホログラフィ技術の世界市場の世界市場動向及び予測
    Digital holography is a 3D technology which produces realistic 3D images of 2D objects with the help of CCD camera. Digital holography is gaining value owing to its growing applications in the medical and retail sectors. The major verticals of this technology such as medical, education, retail, and financial & banking have a large market size in terms of value. The demand for holographic display f …
  • 世界の通信産業展望2015
  • Berkley Renewables Inc.:石油・ガスの開発・生産動向及びコスト分析- 2012
    Berkley Renewables Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Berkley Renewables Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
  • 商用車用アンチロックブレーキ装置(ABS)の世界市場2016-2020
    About Commercial Vehicle Anti-Lock Braking System While driving a vehicle, braking is a mandatory operation that is needed to control the vehicle. There are different road-side driving conditions such as off-highway conditions, city traffic among others that have led to the evolution of the different automotive braking systems. This has led to the development of anti-lock braking systems, autonomo …
  • SDカードの世界市場2016-2020
    About Secure Digital Card SD cards are data storage devices used for storing digital information. These cards have non-volatile memory chips that can be reprogrammed multiple times during their life span. Their compact physical size and high storage capabilities with reprogrammable features have increased the penetration of SD cards in the digital world. Different standards for SD cards came into …
  • 畜牛用飼料&飼料添加剤の世界市場:トウモロコシ、脱脂大豆、小麦、油料種子、穀物、ビタミン、ミネラル、アミノ酸、酵素、酸味料、抗生物質、抗酸化剤
    The cattle feed market is projected to grow at a CAGR of 2.7% from 2015 to 2020 and reach a projected value of USD 72.12 Billion by 2020. The cattle feed additives market is projected to grow at a CAGR of 3.9% from 2015 to 2020, to reach USD 2.72 Billion by 2020. The livestock sector has developed rapidly; however, it is still largely composed of small-scale farms, especially in developing countri …
  • WiMAX Solutions and Market Opportunities
    This report bundle represents the most comprehensive research covering the market for WiMAX solutions and market opportunities. It includes research that covers solution analysis, competitive analysis vs. WiMAX alternatives, market opportunities in various industry verticals, support of WiMAX business plans, network planning, and more. See Table of Contents for complete list of areas covered.
  • 自動車排気装置の世界市場2015-2019
    About automotive exhaust systems Automotive exhaust system is used to guide reaction exhaust gases away from the controlled combustion inside the engine of an automobile. The system includes one or more exhaust pipes depending on the design and requirement. The design of an automotive exhaust system that helps the harmful exhaust gases includes: cylinder head and exhaust manifold; a muffler common …
  • リスクアナリティクス(リスク管理)ソリューションの世界市場
    About Risk Analytics Risk analytics is defined as an effective tool to control risk and use various assumption, risk prevention, and risk retention for managing uncertain events. Risk can be financial as well as operational or strategic in nature. Risk analytics started when financial organizations started realising the loss of their information and capital and thus started developing models and f …
  • 熱可塑性ポリウレタン(TPU)フィルムの世界市場2018-2022
    About Global Thermoplastic Polyurethane (TPU) Films TPU is a class of polyurethane plastics formed by the polyaddition reaction between a diisocyanate and one or more long- or short-chain diols. TPU films exhibit excellent toughness, flexibility, and abrasion resistance. They are used in numerous industries such as automotive, aerospace, construction, and energy. Technavio’s analysts forecast the …
  • 世界の等温核酸増幅技術(INAAT)市場(2014-2018)
    TechNavio’s analysts forecast the Global Isothermal Nucleic Acid Amplification Technologies market will grow at a CAGR of 17.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the technological advances being made in this domain. The Global Isothermal Nucleic Acid Amplification Technologies market has also been witnessing an increase in the miniaturi …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。